NeOnc Technologies Holdings is trading at $2.65, down 11.37%, amid biotech-sector weakness.
- No new company announcement or clearly linked company-specific catalyst was identified for October 7.
- Coverage of FDA meetings concerns previously reported development plans and does not attribute the price move to that news.
- The XBI is down 2.50%; elevated Treasury yields, oil prices and broad risk aversion are adding pressure to markets.